Lumanta, Dexie Ann .
HRN: 23-73-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
CEFUROXIME 500MG (TAB)
11/16/2023
11/22/2023
ORAL
500mg
BID
PROM, Rmle
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes